Global News Blog – Global Analyst / IPS By Patricia Grogg HAVANA, Oct 22, 2010 (IPS) – Cuba’s biotechnology industry is hoping to conquer the European Union market with Heberprot-P, a therapeutic drug used to prevent foot amputations in patients with diabetes. Heberprot-P, developed by the Genetic Engineering and Biotechnology Centre (CIGB), stimulates tissue healing…
Read More
Cuban Treatment for Diabetic Foot Ulcers Heads for Europe
